Mangoceuticals, Inc. (MGRX) has provided an update.
Mangoceuticals, Inc. stockholders convened at a Special Meeting and voted in favor of key proposals, signaling strong support for the company’s strategic initiatives. A significant 91% majority approved a reverse stock split, empowering the Board to determine the ratio, reflecting confidence in the Board’s discretion. Additionally, the stockholders ratified the First Amendment to the 2022 Equity Incentive Plan, ensuring the company’s ability to incentivize its workforce effectively. The potential adjournment of the meeting was also approved but was rendered unnecessary due to the successful passage of the preceding proposals.
Learn more about MGRX stock on TipRanks’ Stock Analysis page.
